record_id string | scenario string | year int64 | setting string | test_method string | medicine_tested string | sample_source string | iso_17025 int64 | who_pq_lab int64 | quality_manual int64 | proficiency_testing int64 | equipment_functional int64 | hplc_available int64 | calibrated_current int64 | maintenance_contract int64 | reagent_available int64 | reference_standard_available int64 | staff_qualified int64 | analyst_trained int64 | staff_count int64 | vacancies int64 | samples_year int64 | turnaround_days int64 | test_completed int64 | result_accurate int64 | sf_detected int64 | api_failure int64 | reported_to_nmra int64 | budget_adequate int64 | donor_funded int64 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
NAT-00000 | national_qc_laboratory | 2,022 | university_lab | Karl_Fischer | anti_TB | post_market | 0 | 0 | 1 | 0 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 10 | 1 | 474 | 62 | 0 | 0 | 0 | 0 | 0 | 0 | 1 |
NAT-00001 | national_qc_laboratory | 2,017 | national_qc_lab | HPLC | analgesic | post_market | 0 | 0 | 0 | 0 | 1 | 1 | 0 | 0 | 1 | 1 | 0 | 0 | 2 | 2 | 504 | 52 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
NAT-00002 | national_qc_laboratory | 2,022 | university_lab | disintegration | analgesic | port_entry | 1 | 0 | 1 | 1 | 0 | 0 | 0 | 0 | 1 | 1 | 1 | 1 | 7 | 2 | 500 | 36 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
NAT-00003 | national_qc_laboratory | 2,020 | national_qc_lab | HPLC | antibiotic | manufacturer | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 1 | 0 | 10 | 1 | 495 | 50 | 0 | 0 | 0 | 0 | 0 | 0 | 1 |
NAT-00004 | national_qc_laboratory | 2,019 | national_qc_lab | visual_inspection | analgesic | port_entry | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 0 | 0 | 0 | 6 | 2 | 503 | 22 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
NAT-00005 | national_qc_laboratory | 2,022 | national_qc_lab | visual_inspection | antimalarial | post_market | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 9 | 3 | 517 | 11 | 0 | 0 | 0 | 0 | 0 | 0 | 1 |
NAT-00006 | national_qc_laboratory | 2,012 | national_qc_lab | disintegration | antidiabetic | post_market | 0 | 0 | 0 | 0 | 1 | 0 | 1 | 0 | 1 | 0 | 1 | 1 | 9 | 2 | 554 | 19 | 1 | 1 | 0 | 0 | 0 | 0 | 1 |
NAT-00007 | national_qc_laboratory | 2,017 | private_contract_lab | disintegration | other | research | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 11 | 0 | 457 | 35 | 0 | 0 | 0 | 0 | 0 | 0 | 1 |
NAT-00008 | national_qc_laboratory | 2,024 | national_qc_lab | HPLC | antibiotic | post_market | 1 | 0 | 1 | 1 | 0 | 0 | 0 | 0 | 1 | 1 | 0 | 0 | 6 | 1 | 492 | 13 | 0 | 0 | 0 | 0 | 0 | 0 | 1 |
NAT-00009 | national_qc_laboratory | 2,011 | regional_qc_lab | visual_inspection | other | research | 0 | 0 | 1 | 0 | 1 | 0 | 0 | 0 | 1 | 1 | 0 | 0 | 6 | 1 | 512 | 49 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
NAT-00010 | national_qc_laboratory | 2,018 | regional_qc_lab | UV_spectroscopy | vaccine | complaint | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 1 | 0 | 11 | 1 | 504 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
NAT-00011 | national_qc_laboratory | 2,018 | university_lab | microbial_limit | antibiotic | post_market | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 10 | 4 | 527 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
NAT-00012 | national_qc_laboratory | 2,017 | regional_qc_lab | HPLC | ARV | port_entry | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 1 | 0 | 5 | 1 | 510 | 28 | 0 | 0 | 0 | 0 | 0 | 1 | 0 |
NAT-00013 | national_qc_laboratory | 2,014 | regional_qc_lab | HPLC | vaccine | manufacturer | 0 | 0 | 1 | 0 | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 7 | 1 | 531 | 43 | 0 | 0 | 0 | 0 | 0 | 1 | 1 |
NAT-00014 | national_qc_laboratory | 2,017 | regional_qc_lab | disintegration | analgesic | post_market | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 5 | 3 | 480 | 13 | 0 | 0 | 0 | 0 | 0 | 1 | 0 |
NAT-00015 | national_qc_laboratory | 2,014 | university_lab | disintegration | anti_TB | routine | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 8 | 1 | 485 | 25 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
NAT-00016 | national_qc_laboratory | 2,022 | private_contract_lab | dissolution | antibiotic | routine | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 3 | 3 | 472 | 23 | 0 | 0 | 0 | 0 | 0 | 1 | 0 |
NAT-00017 | national_qc_laboratory | 2,017 | national_qc_lab | HPLC | other | post_market | 0 | 0 | 0 | 0 | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 10 | 4 | 502 | 28 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
NAT-00018 | national_qc_laboratory | 2,015 | national_qc_lab | HPLC | other | port_entry | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 16 | 0 | 498 | 37 | 0 | 0 | 0 | 0 | 0 | 0 | 1 |
NAT-00019 | national_qc_laboratory | 2,022 | private_contract_lab | TLC | antibiotic | port_entry | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 5 | 3 | 527 | 68 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
NAT-00020 | national_qc_laboratory | 2,014 | private_contract_lab | HPLC | antibiotic | port_entry | 0 | 0 | 1 | 0 | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 6 | 0 | 497 | 48 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
NAT-00021 | national_qc_laboratory | 2,018 | national_qc_lab | visual_inspection | antimalarial | port_entry | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 1 | 0 | 13 | 4 | 558 | 18 | 0 | 0 | 0 | 0 | 0 | 0 | 1 |
NAT-00022 | national_qc_laboratory | 2,018 | national_qc_lab | HPLC | antibiotic | port_entry | 1 | 0 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 0 | 1 | 1 | 9 | 1 | 542 | 13 | 1 | 1 | 0 | 0 | 0 | 1 | 1 |
NAT-00023 | national_qc_laboratory | 2,010 | national_qc_lab | HPLC | antibiotic | routine | 0 | 0 | 0 | 0 | 1 | 1 | 0 | 0 | 1 | 0 | 0 | 0 | 11 | 1 | 515 | 55 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
NAT-00024 | national_qc_laboratory | 2,012 | national_qc_lab | UV_spectroscopy | antibiotic | complaint | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 7 | 2 | 483 | 13 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
NAT-00025 | national_qc_laboratory | 2,019 | regional_qc_lab | microbial_limit | ARV | complaint | 1 | 0 | 0 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 10 | 3 | 535 | 16 | 0 | 0 | 0 | 0 | 0 | 1 | 1 |
NAT-00026 | national_qc_laboratory | 2,010 | private_contract_lab | dissolution | anti_TB | research | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 1 | 1 | 1 | 1 | 6 | 3 | 477 | 21 | 1 | 0 | 0 | 0 | 0 | 1 | 0 |
NAT-00027 | national_qc_laboratory | 2,020 | university_lab | HPLC | antimalarial | post_market | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 1 | 1 | 6 | 3 | 492 | 31 | 0 | 0 | 0 | 0 | 0 | 0 | 1 |
NAT-00028 | national_qc_laboratory | 2,012 | private_contract_lab | HPLC | antimalarial | research | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 10 | 0 | 499 | 34 | 0 | 0 | 0 | 0 | 0 | 0 | 1 |
NAT-00029 | national_qc_laboratory | 2,010 | national_qc_lab | visual_inspection | antimalarial | routine | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 9 | 1 | 455 | 30 | 0 | 0 | 0 | 0 | 0 | 1 | 0 |
NAT-00030 | national_qc_laboratory | 2,024 | national_qc_lab | UV_spectroscopy | ARV | routine | 0 | 0 | 1 | 0 | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 15 | 2 | 464 | 24 | 0 | 0 | 0 | 0 | 0 | 0 | 1 |
NAT-00031 | national_qc_laboratory | 2,013 | regional_qc_lab | Karl_Fischer | antimalarial | routine | 1 | 0 | 1 | 1 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 8 | 3 | 544 | 15 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
NAT-00032 | national_qc_laboratory | 2,015 | national_qc_lab | visual_inspection | other | research | 0 | 0 | 0 | 0 | 1 | 0 | 1 | 0 | 0 | 0 | 1 | 1 | 5 | 3 | 519 | 26 | 0 | 0 | 0 | 0 | 0 | 0 | 1 |
NAT-00033 | national_qc_laboratory | 2,017 | university_lab | microbial_limit | other | post_market | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 12 | 0 | 511 | 40 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
NAT-00034 | national_qc_laboratory | 2,015 | regional_qc_lab | TLC | analgesic | research | 1 | 0 | 1 | 1 | 1 | 0 | 1 | 1 | 1 | 0 | 0 | 0 | 6 | 2 | 493 | 30 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
NAT-00035 | national_qc_laboratory | 2,017 | national_qc_lab | HPLC | antimalarial | routine | 1 | 0 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 11 | 2 | 449 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
NAT-00036 | national_qc_laboratory | 2,022 | university_lab | dissolution | antimalarial | complaint | 0 | 0 | 1 | 0 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 6 | 2 | 479 | 36 | 0 | 0 | 0 | 0 | 0 | 1 | 0 |
NAT-00037 | national_qc_laboratory | 2,016 | national_qc_lab | dissolution | antimalarial | routine | 0 | 0 | 1 | 0 | 1 | 0 | 1 | 0 | 1 | 0 | 0 | 0 | 9 | 4 | 493 | 30 | 0 | 0 | 0 | 0 | 0 | 0 | 1 |
NAT-00038 | national_qc_laboratory | 2,023 | university_lab | dissolution | ARV | port_entry | 0 | 0 | 1 | 0 | 1 | 0 | 1 | 0 | 1 | 0 | 0 | 0 | 6 | 1 | 517 | 17 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
NAT-00039 | national_qc_laboratory | 2,010 | private_contract_lab | dissolution | other | routine | 1 | 1 | 0 | 1 | 1 | 0 | 0 | 0 | 1 | 0 | 1 | 0 | 12 | 3 | 522 | 26 | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
NAT-00040 | national_qc_laboratory | 2,017 | national_qc_lab | TLC | antidiabetic | post_market | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 4 | 1 | 494 | 57 | 0 | 0 | 0 | 0 | 0 | 1 | 0 |
NAT-00041 | national_qc_laboratory | 2,020 | university_lab | dissolution | antibiotic | complaint | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 1 | 0 | 0 | 1 | 1 | 9 | 1 | 562 | 48 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
NAT-00042 | national_qc_laboratory | 2,023 | private_contract_lab | HPLC | vaccine | complaint | 0 | 0 | 0 | 0 | 1 | 1 | 1 | 0 | 1 | 1 | 1 | 1 | 6 | 2 | 482 | 26 | 1 | 1 | 0 | 0 | 0 | 0 | 0 |
NAT-00043 | national_qc_laboratory | 2,020 | national_qc_lab | TLC | antihypertensive | research | 0 | 0 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 8 | 2 | 496 | 11 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
NAT-00044 | national_qc_laboratory | 2,019 | national_qc_lab | disintegration | antibiotic | manufacturer | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 13 | 0 | 478 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 1 |
NAT-00045 | national_qc_laboratory | 2,024 | national_qc_lab | HPLC | antimalarial | complaint | 0 | 0 | 1 | 0 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 10 | 2 | 517 | 31 | 1 | 1 | 0 | 0 | 0 | 0 | 0 |
NAT-00046 | national_qc_laboratory | 2,021 | private_contract_lab | dissolution | antihypertensive | research | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 0 | 0 | 12 | 1 | 507 | 3 | 0 | 0 | 0 | 0 | 0 | 0 | 1 |
NAT-00047 | national_qc_laboratory | 2,013 | national_qc_lab | microbial_limit | ARV | research | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 1 | 0 | 0 | 1 | 1 | 10 | 2 | 479 | 38 | 0 | 0 | 0 | 0 | 0 | 1 | 0 |
NAT-00048 | national_qc_laboratory | 2,016 | national_qc_lab | HPLC | ARV | complaint | 0 | 0 | 0 | 0 | 1 | 1 | 1 | 0 | 1 | 0 | 0 | 0 | 5 | 4 | 483 | 19 | 0 | 0 | 0 | 0 | 0 | 0 | 1 |
NAT-00049 | national_qc_laboratory | 2,016 | national_qc_lab | HPLC | antihypertensive | routine | 0 | 0 | 0 | 0 | 1 | 1 | 1 | 0 | 1 | 0 | 0 | 0 | 11 | 1 | 500 | 27 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
NAT-00050 | national_qc_laboratory | 2,021 | regional_qc_lab | disintegration | antibiotic | routine | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 12 | 2 | 500 | 39 | 0 | 0 | 0 | 0 | 0 | 0 | 1 |
NAT-00051 | national_qc_laboratory | 2,024 | national_qc_lab | UV_spectroscopy | antimalarial | research | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 0 | 0 | 12 | 4 | 480 | 9 | 0 | 0 | 0 | 0 | 0 | 1 | 0 |
NAT-00052 | national_qc_laboratory | 2,012 | regional_qc_lab | disintegration | vaccine | routine | 0 | 0 | 0 | 0 | 1 | 0 | 1 | 0 | 1 | 0 | 1 | 1 | 8 | 3 | 486 | 55 | 1 | 1 | 0 | 0 | 0 | 1 | 0 |
NAT-00053 | national_qc_laboratory | 2,020 | national_qc_lab | dissolution | ARV | post_market | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 11 | 2 | 480 | 29 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
NAT-00054 | national_qc_laboratory | 2,010 | university_lab | HPLC | other | post_market | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 13 | 2 | 496 | 16 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
NAT-00055 | national_qc_laboratory | 2,015 | university_lab | disintegration | analgesic | routine | 0 | 0 | 1 | 0 | 1 | 0 | 1 | 0 | 1 | 1 | 0 | 0 | 5 | 0 | 452 | 27 | 0 | 0 | 0 | 0 | 0 | 0 | 1 |
NAT-00056 | national_qc_laboratory | 2,017 | university_lab | HPLC | vaccine | research | 1 | 0 | 0 | 1 | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 5 | 2 | 496 | 14 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
NAT-00057 | national_qc_laboratory | 2,011 | university_lab | disintegration | antimalarial | post_market | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 1 | 0 | 7 | 3 | 505 | 8 | 0 | 0 | 0 | 0 | 0 | 1 | 0 |
NAT-00058 | national_qc_laboratory | 2,017 | university_lab | dissolution | other | routine | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 1 | 0 | 7 | 2 | 498 | 33 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
NAT-00059 | national_qc_laboratory | 2,023 | university_lab | microbial_limit | antihypertensive | post_market | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 1 | 1 | 1 | 0 | 0 | 6 | 0 | 497 | 21 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
NAT-00060 | national_qc_laboratory | 2,010 | university_lab | dissolution | ARV | post_market | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 7 | 2 | 499 | 39 | 0 | 0 | 0 | 0 | 0 | 1 | 1 |
NAT-00061 | national_qc_laboratory | 2,014 | university_lab | HPLC | ARV | manufacturer | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 1 | 1 | 5 | 1 | 511 | 43 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
NAT-00062 | national_qc_laboratory | 2,016 | private_contract_lab | disintegration | antimalarial | manufacturer | 0 | 1 | 1 | 0 | 1 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 9 | 2 | 467 | 26 | 0 | 0 | 0 | 0 | 0 | 1 | 1 |
NAT-00063 | national_qc_laboratory | 2,016 | national_qc_lab | dissolution | antimalarial | post_market | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 11 | 1 | 519 | 51 | 0 | 0 | 0 | 0 | 0 | 0 | 1 |
NAT-00064 | national_qc_laboratory | 2,017 | national_qc_lab | dissolution | antimalarial | port_entry | 0 | 0 | 0 | 0 | 1 | 0 | 1 | 0 | 1 | 1 | 0 | 0 | 10 | 1 | 523 | 28 | 0 | 0 | 0 | 0 | 0 | 0 | 1 |
NAT-00065 | national_qc_laboratory | 2,021 | national_qc_lab | disintegration | vaccine | post_market | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 0 | 0 | 9 | 0 | 541 | 20 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
NAT-00066 | national_qc_laboratory | 2,013 | private_contract_lab | HPLC | anti_TB | post_market | 1 | 0 | 1 | 0 | 1 | 1 | 0 | 0 | 0 | 0 | 1 | 1 | 6 | 2 | 490 | 27 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
NAT-00067 | national_qc_laboratory | 2,018 | private_contract_lab | TLC | antibiotic | port_entry | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 11 | 1 | 514 | 14 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
NAT-00068 | national_qc_laboratory | 2,015 | private_contract_lab | UV_spectroscopy | antihypertensive | port_entry | 0 | 1 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 9 | 1 | 476 | 2 | 0 | 0 | 0 | 0 | 0 | 0 | 1 |
NAT-00069 | national_qc_laboratory | 2,016 | national_qc_lab | HPLC | other | post_market | 0 | 0 | 0 | 0 | 1 | 1 | 0 | 1 | 1 | 0 | 0 | 0 | 4 | 3 | 528 | 22 | 0 | 0 | 0 | 0 | 0 | 1 | 1 |
NAT-00070 | national_qc_laboratory | 2,014 | university_lab | dissolution | vaccine | complaint | 0 | 0 | 0 | 0 | 1 | 0 | 1 | 0 | 0 | 0 | 1 | 1 | 7 | 2 | 513 | 6 | 0 | 0 | 0 | 0 | 0 | 1 | 1 |
NAT-00071 | national_qc_laboratory | 2,021 | private_contract_lab | HPLC | anti_TB | post_market | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 1 | 1 | 14 | 0 | 482 | 16 | 0 | 0 | 0 | 0 | 0 | 0 | 1 |
NAT-00072 | national_qc_laboratory | 2,022 | national_qc_lab | visual_inspection | anti_TB | post_market | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 10 | 3 | 515 | 19 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
NAT-00073 | national_qc_laboratory | 2,011 | national_qc_lab | disintegration | antidiabetic | routine | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 6 | 3 | 467 | 14 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
NAT-00074 | national_qc_laboratory | 2,012 | university_lab | microbial_limit | ARV | post_market | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 9 | 0 | 481 | 27 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
NAT-00075 | national_qc_laboratory | 2,012 | university_lab | dissolution | antihypertensive | manufacturer | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 6 | 1 | 502 | 42 | 0 | 0 | 0 | 0 | 0 | 1 | 1 |
NAT-00076 | national_qc_laboratory | 2,018 | university_lab | disintegration | other | post_market | 0 | 1 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 5 | 4 | 513 | 26 | 0 | 0 | 0 | 0 | 0 | 0 | 1 |
NAT-00077 | national_qc_laboratory | 2,010 | university_lab | dissolution | antibiotic | complaint | 0 | 0 | 0 | 0 | 1 | 0 | 1 | 0 | 1 | 0 | 0 | 0 | 7 | 2 | 532 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 1 |
NAT-00078 | national_qc_laboratory | 2,013 | private_contract_lab | TLC | other | research | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 1 | 1 | 1 | 1 | 12 | 6 | 523 | 17 | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
NAT-00079 | national_qc_laboratory | 2,014 | regional_qc_lab | dissolution | ARV | post_market | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 12 | 2 | 550 | 30 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
NAT-00080 | national_qc_laboratory | 2,022 | national_qc_lab | dissolution | antidiabetic | routine | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 7 | 3 | 494 | 8 | 0 | 0 | 0 | 0 | 0 | 0 | 1 |
NAT-00081 | national_qc_laboratory | 2,023 | national_qc_lab | HPLC | analgesic | port_entry | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 1 | 0 | 5 | 3 | 531 | 50 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
NAT-00082 | national_qc_laboratory | 2,020 | private_contract_lab | HPLC | antimalarial | post_market | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 6 | 2 | 513 | 24 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
NAT-00083 | national_qc_laboratory | 2,011 | regional_qc_lab | microbial_limit | antidiabetic | routine | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 1 | 1 | 4 | 2 | 485 | 12 | 0 | 0 | 0 | 0 | 0 | 0 | 1 |
NAT-00084 | national_qc_laboratory | 2,011 | private_contract_lab | microbial_limit | anti_TB | complaint | 0 | 0 | 1 | 0 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 6 | 1 | 481 | 31 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
NAT-00085 | national_qc_laboratory | 2,022 | national_qc_lab | TLC | other | routine | 0 | 0 | 0 | 0 | 1 | 0 | 1 | 1 | 1 | 1 | 0 | 0 | 5 | 1 | 480 | 23 | 0 | 0 | 0 | 0 | 0 | 0 | 1 |
NAT-00086 | national_qc_laboratory | 2,011 | university_lab | dissolution | analgesic | post_market | 1 | 0 | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 10 | 3 | 502 | 44 | 0 | 0 | 0 | 0 | 0 | 1 | 1 |
NAT-00087 | national_qc_laboratory | 2,010 | regional_qc_lab | microbial_limit | antibiotic | post_market | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 6 | 3 | 485 | 43 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
NAT-00088 | national_qc_laboratory | 2,012 | regional_qc_lab | HPLC | other | complaint | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 8 | 5 | 530 | 35 | 0 | 0 | 0 | 0 | 0 | 1 | 0 |
NAT-00089 | national_qc_laboratory | 2,014 | national_qc_lab | disintegration | antibiotic | routine | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 8 | 0 | 517 | 28 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
NAT-00090 | national_qc_laboratory | 2,021 | private_contract_lab | HPLC | antimalarial | post_market | 0 | 0 | 0 | 0 | 1 | 1 | 1 | 0 | 0 | 0 | 1 | 0 | 6 | 1 | 492 | 31 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
NAT-00091 | national_qc_laboratory | 2,017 | university_lab | visual_inspection | antimalarial | research | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 1 | 1 | 0 | 0 | 9 | 6 | 507 | 41 | 0 | 0 | 0 | 0 | 0 | 1 | 0 |
NAT-00092 | national_qc_laboratory | 2,021 | national_qc_lab | HPLC | ARV | complaint | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 1 | 1 | 11 | 2 | 497 | 16 | 0 | 0 | 0 | 0 | 0 | 0 | 1 |
NAT-00093 | national_qc_laboratory | 2,012 | national_qc_lab | dissolution | ARV | post_market | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 8 | 5 | 490 | 23 | 0 | 0 | 0 | 0 | 0 | 0 | 1 |
NAT-00094 | national_qc_laboratory | 2,023 | national_qc_lab | microbial_limit | other | post_market | 0 | 0 | 1 | 0 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 5 | 2 | 499 | 33 | 0 | 0 | 0 | 0 | 0 | 1 | 0 |
NAT-00095 | national_qc_laboratory | 2,012 | national_qc_lab | HPLC | antibiotic | routine | 0 | 0 | 0 | 0 | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 4 | 0 | 465 | 45 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
NAT-00096 | national_qc_laboratory | 2,021 | national_qc_lab | HPLC | antimalarial | port_entry | 0 | 0 | 0 | 0 | 1 | 1 | 0 | 0 | 1 | 0 | 0 | 0 | 5 | 2 | 488 | 16 | 0 | 0 | 0 | 0 | 0 | 0 | 1 |
NAT-00097 | national_qc_laboratory | 2,019 | national_qc_lab | TLC | antidiabetic | complaint | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 1 | 1 | 0 | 1 | 1 | 6 | 1 | 509 | 23 | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
NAT-00098 | national_qc_laboratory | 2,011 | regional_qc_lab | HPLC | antimalarial | post_market | 0 | 0 | 0 | 0 | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 8 | 2 | 455 | 52 | 0 | 0 | 0 | 0 | 0 | 1 | 0 |
NAT-00099 | national_qc_laboratory | 2,018 | university_lab | HPLC | antibiotic | routine | 1 | 0 | 1 | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 6 | 1 | 501 | 13 | 0 | 0 | 0 | 0 | 0 | 0 | 1 |
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.